Drug class
Iron replacement; ferrous (Fe2+) iron source
Mechanism of action
Ferrous iron is absorbed primarily in the duodenum and proximal jejunum through divalent metal transporter 1 (DMT1). Absorbed iron enters the circulating transferrin pool and is incorporated into haemoglobin, myoglobin and iron-dependent enzymes. Fumarate, sulfate, succinate and ascorbate salts deliver the same ferrous iron moiety; elemental iron content and formulation affect dosing and tolerability, not the core deficiency indication.
General use cases
- Prevention and treatment of iron deficiency
- Treatment of iron-deficiency anaemia, including in pregnancy where clinically appropriate; elemental iron dose and tolerability depend on the particular salt and formulation
Ferrous iron is the relevant iron moiety; succinate is the counter-ion. Elemental iron content and bioavailability differ by salt, but the general indication is iron replacement.
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
